Sugi Predict

Sugi Predict / Compounds / SCHEMBL21340102

SCHEMBL21340102

SCHEMBL21340102

Cc1cc(C)c(C(=O)N2CCN(c3ccccc3)C(C(N)=O)C2)c(C)c1NC1CCN(c2ccccc2C#N)CC1

nearest known ligand 0.84

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ MTOR P42345 10/20 0.84
▸ RPTOR Q8N122 10/20 0.84
▸ MLST8 Q9BVC4 10/20 0.84
▸ DPP4 P27487 1/20 0.35
▸ DRD4 P21917 1/20 0.35
▸ GRM1 Q13255 1/20 0.35
▸ HCRTR1 O43613 1/20 0.34
▸ HCRTR2 O43614 1/20 0.34
▸ GRM5 P41594 1/20 0.34
▸ MC4R P32245 1/20 0.34
▸ AR P10275 1/20 0.34
▸ KDM1A O60341 1/20 0.33
▸ USP30 Q70CQ3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21340094 0.92 MTOR (1.00) MTORRPTORMLST8HCRTR1HCRTR2
SCHEMBL21360364 0.89 MTOR (0.68) MTORRPTORMLST8DPP4DRD4
SCHEMBL20141235 0.89 MTOR (0.68) MTORRPTORMLST8DPP4DRD4
SCHEMBL20141279 0.88 MTOR (0.67) MTORRPTORMLST8DRD4GRM1
SCHEMBL21360408 0.88 MTOR (0.67) MTORRPTORMLST8DRD4GRM1
SCHEMBL21340103 0.87 MTOR (0.91) MTORRPTORMLST8KDM1A
SCHEMBL21360357 0.85 MTOR (0.62) MTORRPTORMLST8DPP4DRD4
SCHEMBL21360348 0.85 MTOR (0.62) MTORRPTORMLST8DPP4DRD4
SCHEMBL21360350 0.84 MTOR (0.62) MTORRPTORMLST8DRD4HCRTR1
SCHEMBL20141375 0.84 MTOR (0.62) MTORRPTORMLST8DRD4HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 — — US disclosed
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 — — US disclosed
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2020-07-02 — — US disclosed
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2020-07-02 — — US disclosed
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2019-09-17 — — US disclosed
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2019-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.